Industry3h ago
Anthropic Launches Rare Disease Drug Discovery
Anthropic will launch preclinical drug-discovery programs targeting neglected diseases on June 30, 2026. The company also unveiled Claude Science, a specialized AI workbench for researchers. This move pivots Anthropic from a general model provider to a direct biotech player. Practitioners can now access dedicated tools for high-stakes pharmaceutical research.